rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Douglas M. Hunt

Officer

Company insider

Files Form 4 as: Officer, Puma Biotechnology.

In numbers

Trades disclosed
65
Buys
0
Sells
39
Bought
$0
Sold
$608K
Companies
1
Companies where not an officer
0
First trade
16 Jan 2018
Last trade
6 Jul 2026
Last filed
8 Jul 2026

Companies traded

Where they are an officer
PBYI Puma BiotechnologyOfficer · Biotechnology · last 6 Jul 20260 buys · 39 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
6 Jul 2026filed 8 Jul 2026PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Sold$70K8,460 at $8.26filing
6 Jul 2026filed 8 Jul 2026PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Sold$70K8,460 at $8.26filing
18 Feb 2026filed 20 Feb 2026PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Code A—49,394 at $0.00filing
18 Feb 2026filed 20 Feb 2026PBYI Puma Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—70,321 at $0.00filing
18 Feb 2026filed 20 Feb 2026PBYI Puma Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—70,321 at $0.00filing
18 Feb 2026filed 20 Feb 2026PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Code A—49,394 at $0.00filing
7 Jan 2026filed 8 Jan 2026PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Sold$29K5,014 at $5.88filing
7 Jan 2026filed 8 Jan 2026PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Sold$29K5,014 at $5.88filing
6 Jan 2026filed 8 Jan 2026PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Sold$23K3,973 at $5.84filing
6 Jan 2026filed 8 Jan 2026PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Sold$23K3,973 at $5.84filing
9 Jul 2025filed 10 Jul 2025PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Sold$12K3,443 at $3.54filing
8 Jul 2025filed 10 Jul 2025PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Sold$15K4,374 at $3.53filing
7 Feb 2025filed 11 Feb 2025PBYI Puma Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—66,604 at $0.00filing
7 Feb 2025filed 11 Feb 2025PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Code A—48,117 at $0.00filing
2 Jan 2025filed 3 Jan 2025PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Sold$27K8,633 at $3.15filing
17 Jul 2024filed 18 Jul 2024PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Sold$13K3,637 at $3.70filing
2 Jul 2024filed 2 Jul 2024PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Sold$14K4,349 at $3.27filing
12 Feb 2024filed 14 Feb 2024PBYI Puma Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—52,452 at $0.00filing
12 Feb 2024filed 14 Feb 2024PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Code A—37,894 at $0.00filing
3 Jan 2024filed 5 Jan 2024PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Sold$38K8,358 at $4.49filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care39

Buys in green, sells in red, by the company’s sector.

Related people

Troy Edward WilsonDirector · Director at Puma Biotechnology, filing Form 4 there in the last year
Alessandra CesanoDirector · Director at Puma Biotechnology, filing Form 4 there in the last year
Alan H. AuerbachPresident and CEO · President and CEO at Puma Biotechnology, filing Form 4 there in the last year
Maximo F. NouguesChief Financial Officer · Chief Financial Officer at Puma Biotechnology, filing Form 4 there in the last year
Brian M. StuglikDirector · Director at Puma Biotechnology, filing Form 4 there in the last year